Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer.

Transl Androl Urol · 2015 · PMC4708230 · PMID 26816835

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significantP=0.06so close (0.05 < p ≤ 0.1)

The study showed a borderline significant improvement in progression free survival (PFS) in the combination arm compared with ADT alone (HR =0.75, 95% CI, 0.55-1.01; P=0.06).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.